• 互联网药品信息服务资格证书
    证书编号:(粤)-非经营性-2021-0182

  • 营业执照
    证书编号:91440101MA9XNDLX8Q

药直供 > 医药热点 > Tepezza副作用大不大

Tepezza副作用大不大

作者头像
吕锦辉

高级医学编辑,药理学硕士

摘要:The main ingredient of Tepezza is teprotumumab, a monoclonal antibody that targets and inhibits the activity of insulin-like growth factor 1 receptor (IGF-1R). This action helps to reduce the inflammation and tissue expansion behind the eyes, leading to a

有用 0
浏览 101次
2023-09-17 20:15:12 发布

The main ingredient of Tepezza is teprotumumab, a monoclonal antibody that targets and inhibits the activity of insulin-like growth factor 1 receptor (IGF-1R). This action helps to reduce the inflammation and tissue expansion behind the eyes, leading to a decrease in eye protrusion. The efficacy of the drug has been demonstrated in clinical trials, with patients experiencing a reduction in eye bulging, improvement in eye motility, and a decrease in overall symptom severity.

While the benefits of Tepezza are significant, it is important to acknowledge the potential side effects associated with its use. Common side effects reported by patients include muscle spasms, nausea, fatigue, and diarrhea. These side effects are generally mild and manageable, often subsiding over time or with symptom management strategies. However, more severe side effects are possible, although they are less common. These may include liver dysfunction, changes in blood sugar levels, and changes in hormone levels. It is crucial for patients to consult with their healthcare providers and report any concerning or persistent side effects when using Tepezza.

Tepezza

Although Tepezza's side effects may seem concerning, it is essential to understand that risks exist with any medication, and these risks must be weighed against the potential benefits. For many patients, the benefits of using Tepezza in improving their quality of life and reducing eye protrusion outweigh the potential risks of side effects. Monitoring and managing these side effects are crucial for patient safety and well-being.

It is important to note that Tepezza is a prescription medication and should only be used under the supervision of a qualified healthcare professional. Patients must have regular check-ups during treatment to monitor for any changes in health or potential side effects. Additionally, healthcare providers may adjust the dosage or provide additional medications to alleviate side effects if necessary.

In conclusion, Tepezza is a new and innovative treatment option for thyroid eye disease that has shown impressive results in improving eye protrusion and related symptoms. While it does come with potential side effects, most of them are mild and can be managed with appropriate medical support. As with any medication, it is crucial for patients to work closely with their healthcare providers to monitor their health during treatment and address any concerns. Tepezza offers promising benefits for patients suffering from thyroid eye disease and has the potential to greatly improve their well-being and quality of life.

24小时药师咨询 Tepezza的相关介绍
注:本站所有内容仅供参考,不代表药直供立场(如有错漏,请帮忙指正),转载请注明出处。不作为诊断及治疗依据,不可替代专业医师诊断、不可替代医师处方。本站不承担由此导致的相关责任!
2023-09-17 20:15:12 更新
  • Tepezza基本信息

    Tepezza
    • 剂型:

      注射剂

    • 厂家:

      美国Horizon Pharma

    • 适应症:

      治疗甲状腺眼病的新型药物,改善患者眼球突出

特别声明:本站内容仅供参考,不作为诊断及医疗依据。本网站不销售任何药品,只做药品信息资讯展示!

不良信息举报邮箱:zsex@foxmail.com  版权所有 Copyright©2023 www.yzgmall.com All rights reserved

互联网药品信息服务资格证书编号:(粤)-非经营性-2021-0182    |   粤ICP备2021070247号 |   药直供手机端 |   网站地图